Scientists at the Leibniz Institute for Immunotherapy in Germany have discovered that the LMO4 gene can enhance the stemness of T cells, increasing...

Chimeric antigen receptor (CAR) T–cell immunotherapy re-engineers a patient’s immune cells to target cancer cells. While successful in some types...

Natural killer (NK) cells engineered to express interleukin-21 (IL-21) demonstrated sustained antitumor activity against glioblastoma stem cell-like...

An activity pattern in certain genes responsible for building proteins known as spleen tyrosine kinases can predict which melanoma patients are likely...

Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is a protein receptor on T immune cells that prevents the cells from killing other cells, such as cancer...

Announcing a new publication for Acta Materia Medica journal. Ribonucleic acid for injection II is a clinical adjuvant cancer therapy treatment based...

For decades, researchers have worked to develop therapies that can prime the immune system to recognize and attack proteins on the surface of tumor...

Cancer treatments are often powerful and effective, but they can sometimes come with serious side effects. One such treatment involves blocking a...

Researchers demonstrated a way to speed up—and potentially scale up—the process for separating particles in fluids, which can be used for studying...

A new form of immunotherapy using innovative nanoparticles can delay resistance to hormone therapy and help men with prostate cancer live longer....